miércoles, 7 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 18, 2026

Earnings live: Wingstop stock surges on Q4 earnings beat, Garmin spikes, Analog Devices rises

View original at finance.yahoo.com
Earnings live: Wingstop stock surges on Q4 earnings beat, Garmin spikes, Analog Devices rises The software trade is still under pressure. Late Tuesday, shares of cybersecurity giant Palo Alto Networks (PANW) fell as much as 6% after the company cut its full-year earnings outlook…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Crocs issued full-year 2026 profit guidance of $12.88 to $13.35 per share, beating analysts' estimates of $11.92.

    80% confidence

  • For Q1, Coinbase expects subscription and services revenue of $550 million to $630 million.

    80% confidence

  • Analog Devices cited strong demand from industrial and data center customers as the AI boom continues to drive semiconductor sales.

    80% confidence

  • As of Feb. 13, 74% of S&P 500 companies had reported results, and blended earnings growth stood at 13.2%.

    80% confidence

  • As GLP-1 drug adoption grows, consumers eat fewer calories per day and also change the mix of what they eat.

    80% confidence

  • Airbnb forecast Q1 2026 revenue between $2.59 billion and $2.63 billion, above analyst expectations of $2.52 billion, suggesting strong demand for premium bookings.

    80% confidence

  • McDonald's is not going to not win on value, having made significant progress on value and affordability platforms.

    80% confidence

  • Coinbase has seen $420 million of transaction revenue in the first quarter through Feb. 10.

    80% confidence

  • Coinbase user funds are safe despite exchange issues.

    80% confidence

  • General Mills lowered its fiscal 2026 sales forecast due to a more challenging consumer environment.

    80% confidence

  • Garmin forecasts upbeat annual results on strong demand for high-end wearables.

    80% confidence

  • McDonald's is factoring in changing diet preferences such as customers opting for less sugary drinks into its offerings being tested.

    80% confidence

  • If the 13.2% growth rate holds, it would represent the 10th consecutive quarter of annual earnings growth for the S&P 500 and the fifth consecutive quarter of double-digit growth.

    80% confidence

  • Many McDonald's locations would keep the Extra Value Meal deal as it is fundamental in the current operating environment.

    80% confidence

Data points we hold from this source

Coinbase Global · revenue1.78 billion_USD
Coinbase Global · revenue420 million_USD
Coinbase Global · revenue983 million_USD

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
Earnings live: Wingstop stock surges on Q4 earnings beat, Garmin spikes, Analog Devices rises — Source | Via News | es.VIA.NEWS